Press Releases about Moderna Inc
Exposures
COVID-19
Two Appealing Biotech Stocks for Two Distinct investors
August 08, 2022
Via MarketBeat
Topics
Intellectual Property
From Moderna, Inc.
Via AccessWire
Via MarketBeat
From Moderna, Inc.
Via AccessWire
Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)
June 07, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement
June 02, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna to Present at Upcoming Conferences in June 2022
June 01, 2022
From Moderna, Inc.
Via AccessWire
Topics
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.